Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $299.2 million.

  • Sotera Health's Cash & Equivalents fell 246.01% to $299.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $299.2 million, marking a year-over-year decrease of 246.01%. This contributed to the annual value of $277.2 million for FY2024, which is 646.58% down from last year.
  • According to the latest figures from Q3 2025, Sotera Health's Cash & Equivalents is $299.2 million, which was down 246.01% from $332.4 million recorded in Q2 2025.
  • Sotera Health's 5-year Cash & Equivalents high stood at $647.9 million for Q1 2023, and its period low was $106.9 million during Q4 2021.
  • Moreover, its 5-year median value for Cash & Equivalents was $261.1 million (2024), whereas its average is $251.9 million.
  • Per our database at Business Quant, Sotera Health's Cash & Equivalents soared by 43355.4% in 2023 and then plummeted by 5969.85% in 2024.
  • Over the past 5 years, Sotera Health's Cash & Equivalents (Quarter) stood at $106.9 million in 2021, then skyrocketed by 269.65% to $395.2 million in 2022, then dropped by 25.0% to $296.4 million in 2023, then decreased by 6.47% to $277.2 million in 2024, then grew by 7.92% to $299.2 million in 2025.
  • Its Cash & Equivalents was $299.2 million in Q3 2025, compared to $332.4 million in Q2 2025 and $304.4 million in Q1 2025.